(19)
(11) EP 3 183 583 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
17.08.2022 Bulletin 2022/33

(45) Mention of the grant of the patent:
13.07.2022 Bulletin 2022/28

(21) Application number: 15757188.6

(22) Date of filing: 20.08.2015
(51) International Patent Classification (IPC): 
G01N 33/68(2006.01)
(52) Cooperative Patent Classification (CPC):
G01N 33/6878; G01N 2333/70539; G01N 2800/245; G16B 99/00; G16B 20/00; G16B 20/40; G16B 20/20
(86) International application number:
PCT/EP2015/069163
(87) International publication number:
WO 2016/026934 (25.02.2016 Gazette 2016/08)

(54)

METHOD FOR SELECTING A TRANSPLANTATION DONOR OR DONOR MATERIAL USING LOW OR INTERMEDIATE HLA TYPING INFORMATION

VERFAHREN ZUR AUSWAHL EINES TRANSPLANTATIONSSPENDERS ODER SPENDERMATERIALS MITINFORMATIONEN ÜBER HLA-TYPISIERUNG MIT NIEDRIGER ODER MITTLERER AUFLÖSUNG

MÉTHODE DE SÉLECTION D'UNE MATIÈRE DE TYPE DONNEUR OU D'UN DONNEUR DE TRANSPLANTATION À L'AIDE D'INFORMATIONS DE TYPAGE HLA FAIBLE OU INTERMÉDIAIRE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 20.08.2014 EP 14181626
25.08.2014 US 201462041295 P

(43) Date of publication of application:
28.06.2017 Bulletin 2017/26

(73) Proprietor: PIRCHE AG
10627 Berlin (DE)

(72) Inventor:
  • MCCLOSKEY, Daniel
    West Wickham Kent BR4 0DW (GB)

(74) Representative: Hertin und Partner Rechts- und Patentanwälte PartG mbB 
Kurfürstendamm 54/55
10707 Berlin
10707 Berlin (DE)


(56) References cited: : 
WO-A1-2015/169597
   
  • KIRSTEN GENEUGELIJK ET AL: "Predicting Alloreactivity in Transplantation", JOURNAL OF IMMUNOLOGY RESEARCH, vol. 32, no. 9, 1 January 2014 (2014-01-01), pages 2510-12, XP055201699, ISSN: 2314-8861, DOI: 10.1146/annurev.immunol.23.021704.115658
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).